골유도 재생술(GBR) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2033년)

Guided Bone Regeneration Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,030,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,267,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,956,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 골유도 재생술(GBR) 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 주요 시장 역학에 대한 상세한 분석을 통해 시장 전망을 형성하는 촉진요인, 동향, 기회 및 과제에 대한 통찰력을 제공합니다.

주요 인사이트

• 골유도 재생술(GBR) 시장 규모(2024년) : 7억 9,140만 달러
• 2033년 예상 시장 규모(2033년) : 12억 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 4.7%

골유도 재생술(GBR) 시장 - 조사 범위

골 유도 재생(GBR) 기술은 국소 결손 부위의 뼈 조직 재생을 촉진함으로써 재생 치과 및 정형외과에서 중요한 역할을 하고 있습니다. GBR 시장은 치과, 병원 및 정형외과 센터를 대상으로 다양한 임상적 용도에 맞는 다양한 생체 재료, 멤브레인 및 수술기구를 제공하는 다양한 생체 재료, 멤브레인 및 수술기구를 제공합니다. 제공합니다.

시장 성장 촉진요인

세계 골유도 재생술(GBR) 시장은 치주질환의 유병률 증가, 외상 및 질병으로 인한 뼈 결손 발생률 증가, 뼈 관련 질환에 취약한 고령화 인구 증가 등 여러 요인에 의해 촉진되고 있습니다. 생체 재료, 멤브레인 디자인, 최소 침습 수술 기술의 기술 발전은 치료 결과와 환자 회복을 향상시켜 시장 확대를 촉진할 것입니다. 또한, 치과 및 정형외과 전문 분야뿐만 아니라 악안면 수술 및 수의학에 대한 GBR 기술의 적용 확대는 시장 기업에게 새로운 성장 기회를 창출하고 있습니다.

시장 성장 억제요인

유망한 성장 전망에도 불구하고, 골유도 재생술(GBR)의료 시장은 고가의 치료비, 제한적인 상환 범위, 생체재료 및 의료기기의 승인 및 상용화를 관리하는 복잡한 규제와 관련된 문제에 직면해 있습니다. 엄격한 규제 요건과 지역별로 상이한 의료 정책은 제조업체와 의료 서비스 제공업체에게 컴플라이언스 부담을 가중시켜 시장 침투와 사업 전략에 영향을 미칩니다.

시장 기회

골유도 재생술(GBR)의료 시장은 현재 진행 중인 연구개발 활동, 전략적 제휴, 신흥국가의 의료 인프라 확대로 인해 큰 성장 기회를 맞이하고 있습니다. 생체 적합성 재료, 맞춤형 임플란트용 3D 프린팅 기술, 디지털 치과 솔루션의 혁신은 치료 정확도와 환자 결과를 향상시켜 시장 수요를 자극할 것입니다. 또한, 원격 의료 플랫폼과 디지털 헬스 기술의 통합은 환자의 원격 모니터링과 수술 후 관리 관리를 용이하게 하여 치료 순응도와 임상 결과를 개선할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함 사항·제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 개발 동향

제4장 주요 내용

• 제품 채택 분석 : 지역별
• 제품 USP 분석
• 주요 프로모션 전략 : 제조업체별
• 규제 시나리오
• PESTLE 분석
• Porter의 Five Forces 분석
• 밸류체인 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• 2024년 시장 시나리오
• COVID-19와 영향 분석
  • 재료별
  • 용도별
  • 최종사용자별
  • 지역별

제7장 세계의 골유도 재생술(GBR) 시장 수요(수량) 분석

• 과거 시장 수량 분석, 2019년-2023년
• 현재 및 향후 시장 수량 예측, 2024년-2033년
  • 전년대비 성장 동향 분석

제8장 세계의 골유도 재생술(GBR) 시장 - 가격 분석

• 지역별 가격 분석 : 재료별
• 가격 분석
  • 제조업체 레벨
  • 유통업체 레벨
• 세계 평균 가격 분석 벤치마크
• 가격 결정의 전제조건

제9장 세계의 골유도 재생술(GBR) 시장 수요(금액 또는 규모, 백만 달러) 분석

• 과거 시장 매출(백만 달러) 분석, 2019년-2023년
• 현재 및 향후 시장 매출(백만 달러) 예측, 2024년-2033년
  • 전년대비 성장 동향 분석
  • 절대액 기회 분석

제10장 세계의 골유도 재생술(GBR) 시장 분석 : 재료별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러)와 수량 분석 : 재료별, 2019년-2023년
• 현재 및 향후 시장 규모(백만 달러)와 수량 분석과 예측 : 재료별, 2024년-2033년
  • 골이식 대체품
  • 배리어 막
• 시장의 매력 분석 : 재료별

제11장 세계의 골유도 재생술(GBR) 시장 분석 : 용도별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 용도별, 2019년-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 용도별, 2024년-2033년
  • 임플란트학
  • 치주질환학
  • 구강외과
  • 기타
• 시장의 매력 분석 : 용도별

제12장 세계의 골유도 재생술(GBR) 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 최종사용자별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 최종사용자별, 2024년-2033년
  • 병원
  • 치과의원
  • 학술연구센터
  • 외래수술센터(ASC)
• 시장의 매력 분석 : 최종사용자별

제13장 세계의 골유도 재생술(GBR) 시장 분석 : 지역별

• 서론
• 과거 시장 규모(백만 달러)와 수량 분석 : 지역별, 2019년-2023년
• 현재 및 향후 시장 규모(백만 달러)와 수량 분석과 예측 : 지역별, 2024년-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제14장 북미의 골유도 재생술(GBR) 시장 분석

제15장 라틴아메리카의 골유도 재생술(GBR) 시장 분석

제16장 유럽의 골유도 재생술(GBR) 시장 분석

제17장 남아시아의 골유도 재생술(GBR) 시장 분석

제18장 동아시아의 골유도 재생술(GBR) 시장 분석

제19장 오세아니아의 골유도 재생술(GBR) 시장 분석

제20장 중동 및 아프리카(MEA)의 골유도 재생술(GBR) 시장 분석

제21장 시장 구조 분석

• 시장 분석 : 기업 Tier별
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제22장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁 상세 정보
  • Baxter International Inc.
  • Medtronic
  • Stryker Corp.
  • Integra LifeSciences
  • Zimmer Biomet Holdings
  • Dentsply Sirona
  • botiss biomaterials GmbH
  • Geistlich Pharma AG
  • Biotech Dental
  • Dentegris GmbH
  • GENOSS Co.,Ltd.
  • Osstem Implant

제23장 사용된 전제조건과 두자어

제24장 조사 방법

LSH

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the Guided Bone Regeneration (GBR) market. The report provides an in-depth analysis of crucial market dynamics, offering insights into drivers, trends, opportunities, and challenges shaping the market landscape.

Key Insights:

• Guided Bone Regeneration Market Size (2024E): USD 791.4 million
• Projected Market Value (2033F): USD 1,200.00 million
• Global Market Growth Rate (CAGR 2024 to 2033): 4.7%

Guided Bone Regeneration Market - Report Scope:

Guided Bone Regeneration (GBR) techniques play a critical role in regenerative dentistry and orthopedic surgery by facilitating the regeneration of bone tissue in localized defects. These techniques involve the use of barrier membranes and bone graft materials to create a space conducive to bone growth, thereby restoring bone volume and architecture. The GBR market serves dental clinics, hospitals, and orthopedic centers, offering a variety of biomaterials, membranes, and surgical instruments tailored for different clinical applications.

Market Growth Drivers:

The global Guided Bone Regeneration market is driven by several factors, including increasing prevalence of periodontal diseases, rising incidence of bone defects due to trauma or disease, and growing aging population susceptible to bone-related disorders. Technological advancements in biomaterials, membrane designs, and minimally invasive surgical techniques enhance treatment outcomes and patient recovery, fostering market expansion. Moreover, expanding applications of GBR techniques beyond dental and orthopedic specialties into maxillofacial surgery and veterinary medicine create new growth opportunities for market players.

Market Restraints:

Despite promising growth prospects, the Guided Bone Regeneration market faces challenges related to high treatment costs, limited reimbursement coverage, and regulatory complexities governing the approval and commercialization of biomaterials and medical devices. Stringent regulatory requirements and varying healthcare policies across regions impose compliance burdens on manufacturers and healthcare providers, influencing market penetration and operational strategies.

Market Opportunities:

The Guided Bone Regeneration market presents significant growth opportunities driven by ongoing research and development activities, strategic collaborations, and expanding healthcare infrastructure in emerging economies. Innovations in biocompatible materials, 3D printing technologies for customized implants, and digital dentistry solutions enhance treatment precision and patient outcomes, stimulating market demand. Furthermore, the integration of telemedicine platforms and digital health technologies facilitates remote patient monitoring and post-operative care management, improving treatment adherence and clinical outcomes.

Competitive Intelligence and Business Strategy:

Leading players in the global Guided Bone Regeneration market, such as Medtronic,Stryker Corp.,Integra LifeSciences, focus on product innovation, strategic partnerships, and market expansion initiatives to maintain competitive advantage. These companies invest in R&D to develop advanced biomaterials, biodegradable membranes, and patient-specific surgical kits, addressing diverse clinical needs and enhancing treatment efficacy. Collaborations with academic institutions, dental research centers, and regulatory agencies support technology adoption and market access, driving sustainable growth in the dynamic GBR landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Guided Bone Regeneration market globally?
• Which biomaterials and membrane technologies are driving adoption of GBR techniques across dental and orthopedic specialties?
• How are technological advancements reshaping the competitive landscape of the Guided Bone Regeneration market?
• Who are the key players contributing to the Guided Bone Regeneration market, and what strategies are they employing to sustain market leadership?
• What are the emerging trends and future prospects in the global Guided Bone Regeneration market?

Key Companies Profiled

• Baxter International Inc.
• Medtronic
• Stryker Corp.
• Integra LifeSciences
• Zimmer Biomet Holdings
• Dentsply Sirona
• botiss biomaterials GmbH
• Geistlich Pharma AG
• Biotech Dental
• Dentegris GmbH
• GENOSS Co., Ltd.
• Osstem Implant

Guided Bone Regeneration Industry Research Segmentation

By Material:

• Bone Graft Substitutes
• Barrier Membranes

By Application:

• Implantology
• Periodontology
• Oral and Maxillofacial Surgery

By End User:

• Hospitals
• Dental Clinics
• Academic & Research Centers
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion And Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Development Trends

4. Key Inclusions

• 4.1. Product Adoption Analysis by Region
• 4.2. Product USP Analysis
• 4.3. Key Promotional Strategies by Manufacturers
• 4.4. Regulatory Scenario
• 4.5. PESTLE Analysis
• 4.6. Porter's Analysis
• 4.7. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Industry Outlook
  • 5.1.3. Global Bone Regeneration Market Overview
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Companies Historical Growth
  • 5.2.2. Increasing Prevalence of Dental Diseases
  • 5.2.3. Adoption of Minimally Invasive Procedures
  • 5.2.4. Increasing Prevalence of Bone Related disorders
  • 5.2.5. New Product launches and approvals
  • 5.2.6. Regulatory Policies
  • 5.2.7. Historic and Current Revenue of key players
  • 5.2.8. Technology advancements
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. 2024 Market Scenario
• 6.2. COVID-19 and Impact Analysis
  • 6.2.1. By Material
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Region

7. Global Guided Bone Regeneration Market Demand (Volume) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Volume ('000 Units) Analysis, 2019-2023
• 7.2. Current and Future Market Volume ('000 Units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Guided Bone Regeneration Market - Pricing Analysis

• 8.1. Regional Pricing Analysis By Material
• 8.2. Pricing Break Up
  • 8.2.1. Manufacturer Level
  • 8.2.2. Distributor Level
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Guided Bone Regeneration Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Material

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Material, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Material, 2024-2033
  • 10.3.1. Bone Graft Substitutes
    • 10.3.1.1. Allograft
    • 10.3.1.2. Xenograft
    • 10.3.1.3. Synthetic Bone Graft
    • 10.3.1.4. Others
  • 10.3.2. Barrier Membrane
    • 10.3.2.1. Expanded polytetrafluoroethylene (e-PTFE)
    • 10.3.2.2. High-density polytetrafluoroethylene (d-PTFE)
    • 10.3.2.3. Titanium mesh and titanium-reinforced PTFE
• 10.4. Market Attractiveness Analysis By Material

11. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
  • 11.3.1. Implantology
  • 11.3.2. Periodontology
  • 11.3.3. Oral and Maxillofacial surgery
  • 11.3.4. Others
• 11.4. Market Attractiveness Analysis By Application

12. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
  • 12.3.1. Hospitals
  • 12.3.2. Dental Clinics
  • 12.3.3. Academic & Research Centers
  • 12.3.4. Ambulatory Surgical Centers
• 12.4. Market Attractiveness Analysis By End User

13. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) and Volume ('000 Units)Analysis By Region, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Region, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa
• 13.4. Market Attractiveness Analysis By Region

14. North America Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Material
  • 14.3.3. By Application
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Material
  • 14.4.3. By Application
  • 14.4.4. By End User
• 14.5. Key Market Participants - Intensity Mapping
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Country Level Analysis & Forecast
  • 14.7.1. U.S. Guided Bone Regeneration Market
    • 14.7.1.1. Introduction
    • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.7.1.2.1. By Material
      • 14.7.1.2.2. By Application
      • 14.7.1.2.3. By End User
  • 14.7.2. Canada Guided Bone Regeneration Market
    • 14.7.2.1. Introduction
    • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.7.2.2.1. By Material
      • 14.7.2.2.2. By Application
      • 14.7.2.2.3. By End User

15. Latin America Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Brazil
    • 15.3.1.2. Mexico
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Material
  • 15.3.3. By Application
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Material
  • 15.4.3. By Application
  • 15.4.4. By End User
• 15.5. Key Market Participants - Intensity Mapping
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Country Level Analysis & Forecast
  • 15.7.1. Brazil Guided Bone Regeneration Market
    • 15.7.1.1. Introduction
    • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.7.1.2.1. By Material
      • 15.7.1.2.2. By Application
      • 15.7.1.2.3. By End User
  • 15.7.2. Mexico Portable Multi-Parameter Monitors Market
    • 15.7.2.1. Introduction
    • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.7.2.2.1. By Material
      • 15.7.2.2.2. By Application
      • 15.7.2.2.3. By End User
  • 15.7.3. Argentina Guided Bone Regeneration Market
    • 15.7.3.1. Introduction
    • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.7.3.2.1. By Material
      • 15.7.3.2.2. By Application
      • 15.7.3.2.3. By End User

16. Europe Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Russia
    • 16.3.1.8. Nordic Countries
    • 16.3.1.9. Rest of Europe
  • 16.3.2. By Material
  • 16.3.3. By Portability
  • 16.3.4. By Application
  • 16.3.5. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Material
  • 16.4.3. By Application
  • 16.4.4. By End User
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Country Level Analysis & Forecast
  • 16.7.1. Germany Guided Bone Regeneration Market
    • 16.7.1.1. Introduction
    • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.1.2.1. By Material
      • 16.7.1.2.2. By Application
      • 16.7.1.2.3. By End User
  • 16.7.2. Italy Guided Bone Regeneration Market
    • 16.7.2.1. Introduction
    • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.2.2.1. By Material
      • 16.7.2.2.2. By Application
      • 16.7.2.2.3. By End User
  • 16.7.3. France Guided Bone Regeneration Market
    • 16.7.3.1. Introduction
    • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.3.2.1. By Material
      • 16.7.3.2.2. By Application
      • 16.7.3.2.3. By End User
  • 16.7.4. U.K. Guided Bone Regeneration Market
    • 16.7.4.1. Introduction
    • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.4.2.1. By Material
      • 16.7.4.2.2. By Application
      • 16.7.4.2.3. By End User
  • 16.7.5. Spain Guided Bone Regeneration Market
    • 16.7.5.1. Introduction
    • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.5.2.1. By Material
      • 16.7.5.2.2. By Application
      • 16.7.5.2.3. By End User
  • 16.7.6. BENULUX Guided Bone Regeneration Market
    • 16.7.6.1. Introduction
    • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.6.2.1. By Material
      • 16.7.6.2.2. By Application
      • 16.7.6.2.3. By End User
  • 16.7.7. Russia Guided Bone Regeneration Market
    • 16.7.7.1. Introduction
    • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.7.2.1. By Material
      • 16.7.7.2.2. By Application
      • 16.7.7.2.3. By End User
  • 16.7.8. Nordic Countries Guided Bone Regeneration Market
    • 16.7.8.1. Introduction
    • 16.7.8.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.8.2.1. By Material
      • 16.7.8.2.2. By Application
      • 16.7.8.2.3. By End User

17. South Asia Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Thailand
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Material
  • 17.3.3. By Application
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Material
  • 17.4.3. By Application
  • 17.4.4. By End User
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Country Level Analysis & Forecast
  • 17.7.1. India Guided Bone Regeneration Market
    • 17.7.1.1. Introduction
    • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.7.1.2.1. By Material
      • 17.7.1.2.2. By Application
      • 17.7.1.2.3. By End User
  • 17.7.2. Indonesia Guided Bone Regeneration Market
    • 17.7.2.1. Introduction
    • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.7.2.2.1. By Material
      • 17.7.2.2.2. By Application
      • 17.7.2.2.3. By End User
  • 17.7.3. Malaysia Guided Bone Regeneration Market
    • 17.7.3.1. Introduction
    • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.7.3.2.1. By Material
      • 17.7.3.2.2. By Application
      • 17.7.3.2.3. By End User
  • 17.7.4. Thailand Guided Bone Regeneration Market
    • 17.7.4.1. Introduction
    • 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.7.4.2.1. By Material
      • 17.7.4.2.2. By Application
      • 17.7.4.2.3. By End User

18. East Asia Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Material
  • 18.3.3. By Application
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Material
  • 18.4.3. By Application
  • 18.4.4. By End User
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Country Level Analysis & Forecast
  • 18.7.1. China Guided Bone Regeneration Market
    • 18.7.1.1. Introduction
    • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.7.1.2.1. By Material
      • 18.7.1.2.2. By Application
      • 18.7.1.2.3. By End User
  • 18.7.2. Japan Guided Bone Regeneration Market
    • 18.7.2.1. Introduction
    • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.7.2.2.1. By Material
      • 18.7.2.2.2. By Application
      • 18.7.2.2.3. By End User
  • 18.7.3. South Korea Guided Bone Regeneration Market
    • 18.7.3.1. Introduction
    • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.7.3.2.1. By Material
      • 18.7.3.2.2. By Application
      • 18.7.3.2.3. By End User

19. Oceania Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Material
  • 19.3.3. By Application
  • 19.3.4. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Material
  • 19.4.3. By Application
  • 19.4.4. By End User
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Country Level Analysis & Forecast
  • 19.7.1. Australia Guided Bone Regeneration Market
    • 19.7.1.1. Introduction
    • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.7.1.2.1. By Material
      • 19.7.1.2.2. By Application
      • 19.7.1.2.3. By End User
  • 19.7.2. New Zealand Guided Bone Regeneration Market
    • 19.7.2.1. Introduction
    • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.7.2.2.1. By Material
      • 19.7.2.2.2. By Application
      • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkey
    • 20.3.1.3. North Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Material
  • 20.3.3. By Application
  • 20.3.4. By End User
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Material
  • 20.4.3. By Application
  • 20.4.4. By End User
• 20.5. Key Market Participants - Intensity Mapping
• 20.6. Drivers and Restraints - Impact Analysis
• 20.7. Country Level Analysis & Forecast
  • 20.7.1. GCC Countries Guided Bone Regeneration Market
    • 20.7.1.1. Introduction
    • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.7.1.2.1. By Material
      • 20.7.1.2.2. By Application
      • 20.7.1.2.3. By End User
  • 20.7.2. Turkey Guided Bone Regeneration Market
    • 20.7.2.1. Introduction
    • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.7.2.2.1. By Material
      • 20.7.2.2.2. By Application
      • 20.7.2.2.3. By End User
  • 20.7.3. North Africa Guided Bone Regeneration Market
    • 20.7.3.1. Introduction
    • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.7.3.2.1. By Material
      • 20.7.3.2.2. By Application
      • 20.7.3.2.3. By End User
  • 20.7.4. South Africa Guided Bone Regeneration Market
    • 20.7.4.1. Introduction
    • 20.7.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.7.4.2.1. By Material
      • 20.7.4.2.2. By Application
      • 20.7.4.2.3. By End User

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Presence Analysis
  • 21.3.1. Regional footprint of Players
  • 21.3.2. Material footprint by Players
  • 21.3.3. Channel footprint by Players

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Baxter International Inc.
    • 22.3.1.1. Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.1.4. Sales Footprint
    • 22.3.1.5. SWOT Analysis
    • 22.3.1.6. Key Developments
    • 22.3.1.7. Strategy Overview
      • 22.3.1.7.1. Channel Strategy
      • 22.3.1.7.2. Marketing Strategy
      • 22.3.1.7.3. Material Strategy
  • 22.3.2. Medtronic
    • 22.3.2.1. Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.2.4. Sales Footprint
    • 22.3.2.5. SWOT Analysis
    • 22.3.2.6. Key Developments
    • 22.3.2.7. Strategy Overview
      • 22.3.2.7.1. Channel Strategy
      • 22.3.2.7.2. Marketing Strategy
      • 22.3.2.7.3. Material Strategy
  • 22.3.3. Stryker Corp.
    • 22.3.3.1. Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.3.4. Sales Footprint
    • 22.3.3.5. SWOT Analysis
    • 22.3.3.6. Key Developments
    • 22.3.3.7. Strategy Overview
      • 22.3.3.7.1. Channel Strategy
      • 22.3.3.7.2. Marketing Strategy
      • 22.3.3.7.3. Material Strategy
  • 22.3.4. Integra LifeSciences
    • 22.3.4.1. Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.4.4. Sales Footprint
    • 22.3.4.5. SWOT Analysis
    • 22.3.4.6. Key Developments
    • 22.3.4.7. Strategy Overview
      • 22.3.4.7.1. Channel Strategy
      • 22.3.4.7.2. Marketing Strategy
      • 22.3.4.7.3. Material Strategy
  • 22.3.5. Zimmer Biomet Holdings
    • 22.3.5.1. Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.5.4. Sales Footprint
    • 22.3.5.5. SWOT Analysis
    • 22.3.5.6. Key Developments
    • 22.3.5.7. Strategy Overview
      • 22.3.5.7.1. Channel Strategy
      • 22.3.5.7.2. Marketing Strategy
      • 22.3.5.7.3. Material Strategy
  • 22.3.6. Dentsply Sirona
    • 22.3.6.1. Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.6.4. Sales Footprint
    • 22.3.6.5. SWOT Analysis
    • 22.3.6.6. Key Developments
    • 22.3.6.7. Strategy Overview
      • 22.3.6.7.1. Channel Strategy
      • 22.3.6.7.2. Marketing Strategy
      • 22.3.6.7.3. Material Strategy
  • 22.3.7. botiss biomaterials GmbH
    • 22.3.7.1. Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.7.4. Sales Footprint
    • 22.3.7.5. SWOT Analysis
    • 22.3.7.6. Key Developments
    • 22.3.7.7. Strategy Overview
      • 22.3.7.7.1. Channel Strategy
      • 22.3.7.7.2. Marketing Strategy
      • 22.3.7.7.3. Material Strategy
  • 22.3.8. Geistlich Pharma AG
    • 22.3.8.1. Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.8.4. Sales Footprint
    • 22.3.8.5. SWOT Analysis
    • 22.3.8.6. Key Developments
    • 22.3.8.7. Strategy Overview
      • 22.3.8.7.1. Channel Strategy
      • 22.3.8.7.2. Marketing Strategy
      • 22.3.8.7.3. Material Strategy
  • 22.3.9. Biotech Dental
    • 22.3.9.1. Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.9.4. Sales Footprint
    • 22.3.9.5. SWOT Analysis
    • 22.3.9.6. Key Developments
    • 22.3.9.7. Strategy Overview
      • 22.3.9.7.1. Channel Strategy
      • 22.3.9.7.2. Marketing Strategy
      • 22.3.9.7.3. Material Strategy
  • 22.3.10. Dentegris GmbH
    • 22.3.10.1. Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.10.4. Sales Footprint
    • 22.3.10.5. SWOT Analysis
    • 22.3.10.6. Key Developments
    • 22.3.10.7. Strategy Overview
      • 22.3.10.7.1. Channel Strategy
      • 22.3.10.7.2. Marketing Strategy
      • 22.3.10.7.3. Material Strategy
  • 22.3.11. GENOSS Co.,Ltd.
    • 22.3.11.1. Overview
    • 22.3.11.2. Product Portfolio
    • 22.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.11.4. Sales Footprint
    • 22.3.11.5. SWOT Analysis
    • 22.3.11.6. Key Developments
    • 22.3.11.7. Strategy Overview
      • 22.3.11.7.1. Channel Strategy
      • 22.3.11.7.2. Marketing Strategy
      • 22.3.11.7.3. Material Strategy
  • 22.3.12. Osstem Implant
    • 22.3.12.1. Overview
    • 22.3.12.2. Product Portfolio
    • 22.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
    • 22.3.12.4. Sales Footprint
    • 22.3.12.5. SWOT Analysis
    • 22.3.12.6. Key Developments
    • 22.3.12.7. Strategy Overview
      • 22.3.12.7.1. Channel Strategy
      • 22.3.12.7.2. Marketing Strategy
      • 22.3.12.7.3. Material Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

관련자료